Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Judith M. Boer*, Maria Grazia Valsecchi, Femke M. Hormann, Željko Antić, Marketa Zaliova, Claire Schwab, Giovanni Cazzaniga, Chloé Arfeuille, Hélène Cavé, Andishe Attarbaschi, Sabine Strehl, Gabriele Escherich, Toshihiko Imamura, Kentaro Ohki, Tanja A. Grüber, Rosemary Sutton, Agata Pastorczak, Tim Lammens, Frédéric Lambert, Chi Kong LiEnrique Carrillo de Santa Pau, Steve Hoffmann, Anja Möricke, Christine J. Harrison, Monique L. Den Boer, Paola De Lorenzo, Ronald W. Stam, Anke K. Bergmann, Rob Pieters

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

10 Citations (Scopus)
2 Downloads (Pure)
Original languageEnglish
Pages (from-to)2978-2982
Number of pages5
JournalLeukemia
Volume35
Issue number10
Early online date1 Jul 2021
DOIs
Publication statusPublished - Oct 2021

Bibliographical note

Acknowledgements:
This study was conducted on behalf of the Ponte di Legno Childhood ALL Working Group. The authors gratefully acknowledge samples and data provided by the Blood Cancer UK Childhood Leukaemia Cell Bank, the Center for Biological Resources (CRB-cancer; BB-0033-00076) of the Robert Debré Hospital, the Sydney Children’s Tumour Bank Network, the Vienna BioCenter Core Facilities (VBCF; www.viennabiocenter.org/ facilities) Next-Generation Sequencing Unit, and the Blueprint Consortium. The authors would like to thank Karin Nebral and Oskar A. Haas for providing genetic data, Georg Mann for clinical data and patient samples, Dagmar Schinnerl for bioinformatics analysis of RNA-sequencing data (Berlin-Frankfurt-Münster – Austria study group), Tomasz Szczepanski and Wojciech Mlynarski (Polish Pediatric Leukaemia and Lymphoma Study Group), Martin Schrappe and Martin Zimmermann (Berlin-Frankfurt-Münster - Germany/ Switzerland study group), Alex Hoogkamer and Valerie de Haas (Dutch Childhood Oncology Group), Udo zur Stadt (Cooperative Study Group for Childhood ALL), Benoit Brethon (Société Française de la lutte contre les Cancers et les leucémies de l’Enfant et de l’Adolescent), and Rishi Kotecha (Australian & New Zealand Childrens Hematology/ Oncology Group). This project was supported by grants from the Oncode Institute (M.L. D.B.), Stichting Kinderoncologisch Centrum Rotterdam (M.L.D.B.), KiKa Foundation (KiKa-264; J.M.B.), vzw Kinderkankerfonds (T.L.), DFG grants (BE6555/1-1 (AKB), BE6555/2-1 (A. K.B., S.H.)), Anniversary Fund of the Oesterreichische Nationalbank (OeNB 18281; S.S.), Polpharma Scientific Foundation, grant No. 4/19/IX/1, the ERA-NET TRANSCAN EJC granted by Fondation ARC (www.fondation-arc.org) (A.P.), and European Union’s Seventh Framework Program (FP7/2007–2013, 282510 (BLUEPRINT)).

Cite this